One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

In a phase 3 trial, tolebrutinib has a significant effect on slowing disability progression in some patients with multiple sclerosis..

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

Patient advocacy groups are often funded through pharmaceutical companies, but there are currently no regulations governing ...

On September 20, the FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone in the first line for patients ...

The Digital Markets, Competition and Consumers Act 2024 (UK DMCC) introduces significant reforms to the UK’s Competition and Markets Authority ...

Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and ...

Having a diversified portfolio is pretty much Investing 101, right? I mean, it’s one of the first things we all learn as ...

Patient groups should be playing a central role in Canada's health-care system, advocating for their members by promoting the ...

Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...

Big Pharma is investing heavily in AI to slash development timelines and foster innovation. | Big Pharma is investing heavily ...